BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO)

CUSIP: 090572207

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Class B Common Stock
Shares outstanding
5,071,025
Total 13F shares
19,188,664
Share change
+425,054
Total reported value
$4,671,911,959
Put/Call ratio
113%
Price per share
$243.56
Number of holders
429
Value change
+$52,969,583
Number of buys
191
Number of sells
246

Quarterly Holders Quick Answers

What is CUSIP 090572207?
CUSIP 090572207 identifies BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Alice N. Schwartz
3/4/5
Director Emeritus, 10%+ Owner
mixed-class rows
11,862,229
mixed-class rows
$3,592,267,092 26 Aug 2024
Steven D. Schwartz
3/4/5
10%+ Owner
mixed-class rows
8,560,438
mixed-class rows
$2,584,683,847 26 Aug 2024
BlackRock, Inc.
13F
Company
40%
2,011,649
$660,846,457 31 Dec 2024
13F
VANGUARD GROUP INC
13F 13D/G
Company · The Vanguard Group - 23-1945930
8.4%
from 13D/G
1,919,808
$630,676,126 31 Dec 2024
Veritas Asset Management LLP
13F
Company
19%
976,827
$320,897,438 31 Dec 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
15%
746,119
$245,105,714 31 Dec 2024
13F
VAN ECK ASSOCIATES CORP
13F
Company
14%
723,471
$237,667,000 31 Dec 2024
13F
First Eagle Investment Management, LLC
13F
Company
14%
713,505
$234,393,527 31 Dec 2024
13F
STATE STREET CORP
13F
Company
14%
690,165
$226,708,080 31 Dec 2024
13F
EARNEST PARTNERS LLC
13F
Company
12%
618,049
$203,035,277 31 Dec 2024
13F
ARIEL INVESTMENTS, LLC
13F
Company
11%
560,524
$184,137,739 31 Dec 2024
13F
Select Equity Group, L.P.
13F
Company
9.1%
460,658
$151,330,760 31 Dec 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
8.4%
427,292
$140,369,696 31 Dec 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
7.7%
388,627
$127,667,857 31 Dec 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
7.5%
379,077
$124,530,585 31 Dec 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
6.3%
321,977
$105,586,457 31 Dec 2024
13F
PARNASSUS INVESTMENTS, LLC
13F
Company
6.1%
310,867
$102,122,918 31 Dec 2024
13F
SOUTHEASTERN ASSET MANAGEMENT INC/TN/
13F
Company
6.1%
308,469
$101,335,151 31 Dec 2024
13F
SEI INVESTMENTS CO
13F
Company
5.4%
271,387
$89,156,050 31 Dec 2024
13F
Bank of New York Mellon Corp
13F
Company
5.3%
267,306
$87,812,596 31 Dec 2024
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
5.2%
264,605
$86,925,389 31 Dec 2024
13F
NORTHERN TRUST CORP
13F
Company
5.1%
260,868
$85,697,747 31 Dec 2024
13F
THOMPSON SIEGEL & WALMSLEY LLC
13F
Company
5.1%
258,153
$84,806,000 31 Dec 2024
13F
Mawer Investment Management Ltd.
13F
Company
5.1%
256,927
$84,403,089 31 Dec 2024
13F
MORGAN STANLEY
13F
Company
mixed-class rows
248,998
mixed-class rows
$81,794,500 31 Dec 2024
13F
Point72 Asset Management, L.P.
13F
Company
4.9%
247,510
$81,309,593 31 Dec 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
3.8%
191,867
$63,030,228 31 Dec 2024
13F
First Pacific Advisors, LP
13F
Company
3.1%
157,850
$51,855,304 31 Dec 2024
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
3%
151,644
$49,816,570 31 Dec 2024
13F
Artisan Partners Limited Partnership
13F
Company
2.9%
149,293
$49,044,243 31 Dec 2024
13F
GW&K Investment Management, LLC
13F
Company
2.9%
145,444
$47,780,000 31 Dec 2024
13F
Allspring Global Investments Holdings, LLC
13F
Company
2.8%
143,737
$46,881,259 31 Dec 2024
13F
FEDERATED HERMES, INC.
13F
Company
2.7%
137,561
$45,190,164 31 Dec 2024
13F
FRANKLIN RESOURCES INC
13F
Company
2.7%
135,057
$44,367,575 31 Dec 2024
13F
NORGES BANK
13F
Company
2.5%
126,766
$41,643,899 31 Dec 2024
13F
QVIDTVM Management LLC
13F
Company
2.3%
118,947
$39,075,279 31 Dec 2024
13F
Tikvah Management LLC
13F
Company
2.3%
118,147
$38,812,471 31 Dec 2024
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
2.1%
107,195
$35,214,629 31 Dec 2024
13F
Fisher Asset Management, LLC
13F
Company
2.1%
106,871
$35,108,191 31 Dec 2024
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
2.1%
105,027
$34,502,439 31 Dec 2024
13F
ANCHOR CAPITAL ADVISORS LLC
13F
Company
1.9%
97,207
$31,933,611 31 Dec 2024
13F
WEDGE CAPITAL MANAGEMENT L L P/NC
13F
Company
1.7%
87,487
$28,740,354 31 Dec 2024
13F
DAVENPORT & Co LLC
13F
Company
1.7%
84,677
$27,817,241 31 Dec 2024
13F
UBS Group AG
13F
Company
mixed-class rows
79,287
mixed-class rows
$26,046,567 31 Dec 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.4%
72,132
$23,696,083 31 Dec 2024
13F
Marathon Asset Management Ltd
13F
Company
1.3%
67,127
$22,051,891 31 Dec 2024
13F
COMERICA BANK
13F
Company
1.2%
59,775
$19,636,574 31 Dec 2024
13F
Legal & General Group Plc
13F
Company
1.2%
58,932
$19,359,751 31 Dec 2024
13F
Hound Partners, LLC
13F
Company
1.2%
58,858
$19,335,442 31 Dec 2024
13F
Hosking Partners LLP
13F
Company
1.1%
54,992
$18,065,422 31 Dec 2024
13F

Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q1 2025

As of 31 Mar 2025, BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) was held by 429 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,188,664 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, First Eagle Investment Management, LLC, Veritas Asset Management LLP, DIMENSIONAL FUND ADVISORS LP, ARIEL INVESTMENTS, LLC, STATE STREET CORP, EARNEST PARTNERS LLC, VAN ECK ASSOCIATES CORP, and BANK OF AMERICA CORP /DE/. This page lists 430 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
450
Q1 2025 holders
429
Holder diff
-21
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .